Login / Signup

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?

Michael HaLedibabari M NgaageKevin ZhuNicholas W HriczSheri SlezakYvonne M Rasko
Published in: Aesthetic surgery journal (2021)
There was notable intercompany variation in the coverage of BIA-ALCL treatment, some of which is unnecessarily based on whether the original reason for the breast implant was cosmetic or medically necessary. This variability may significantly reduce access to definitive treatment in patients with a BIA-ALCL diagnosis.
Keyphrases
  • single cell
  • soft tissue
  • diffuse large b cell lymphoma
  • healthcare
  • combination therapy
  • bone marrow